Inhibition of the cAMP signaling cascade via cannabinoid receptors: A putative mechanism of immune modulation by cannabinoid compounds

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 59-63

  Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

9 Tetrahydrocanabinol; cAMP; Cannabinoids; Cannabinol; Immune suppression

Indexed keywords

ADENYLATE CYCLASE; CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG PROTEIN BINDING; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; IMMUNOMODULATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CYCLIC AMP; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 4243781531     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00284-7     Document Type: Conference Paper

References (26)

1. Condie, R., Herring, A., Koh, W.S., Lee, M., Kaminski, N.E., 1996. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and IL-2 expression in the murine T cell line, EL4.IL-2. J. Biol. Chem. 271, 13175-13183.
2. Devane, W.A., Hanus, L., Breuer, A., et al., 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
3. Felder, C.C., Briley, E.M., Axelrod, J., Simpson, J.T., Mackie, K., Devane, W.A., 1993. Anandamide, an endogenous cannabinmimetic eicosinoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 90, 7656-7660.
4. Freier, D.O., Fuchs, B.A., Kaminski, N.E., 1996. Mechanisms of immunotoxicology by drugs of abuse: cannabinoids and opiates. In: Smialowicz, R., Holsapple, M.P. (Eds.), Experimental Immunotoxicology. CRC Press, Boca Raton, pp. 367-388.
5. Friedman, H., Shrivers, S.C., Klein, T.W., 1995. Drugs of abuse and the immune system. In: Dean, J., Luster, M., Munson, A., Kimber, I. (Eds.), Immunotoxicology and Immunopharmacology. Raven Press, New York, pp. 303-322.
6. Grieco, D., Porcellini, A., Avvedimento, E.V., Gottesman, M.E., 1996. Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science 271, 1718-1723.
7. Hadden, J.W., Hadden, E.M., Haddox, M.K., Goldberg, N.D., 1972. Guanosine 3′:5′-cyclic monophosphates: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 69, 3024-3027.
8. Herring, A., Koh, W.S., Kaminski, N.E., 1998. Inhibiting of the cAMP signaling cascade and nuclear factor binding to CRE and κB elements by cannabinol, a minimally CNS-active cannabinoid. Biochem. Pharmacol. 55, 1013-1023.
9. Hsueh, Y.P., Lai, M.Z., 1995. c-jun N-Terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J. Biol. Chem. 270, 18094-18098.
10. 1. Proc. Natl. Acad. Sci. U.S.A. 83, 6072-6076.
11. Kaminski, N.E., 1994. Mechanisms of immune modulation by cannabinoids. In: Dean, J., Luster, M., Munson, A., Kimber, I. (Eds.), Immunopharmacology and Immunotoxicology. Raven Press, New York, pp. 349-362.
12. Kaminski, N.E., Koh, W.S., Lee, M., Yang, K.H., Kessler, F.K., 1994. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G protein coupled mechanism. Biochem. Pharmacol. 48, 1899-1908.
13. Kammer, G.M., 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9, 222-229.
14. Koh, W.S., Yang, K.H., Kaminski, N.E., 1995. Cyclic AMP is an essential factor in immune responses. Biochem. Biophys. Res. Commun. 206, 703-709.
15. Lee, M., Yang, K.H., Kaminski, N.B., 1995. Effect of putative endogenous cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275, 529-536.
16. Maraguchi, A., Miyazaki, K., Fauci, A.S., 1984. Inhibition of human B cell activation by diterpine forskolin: Interference with B cell growth factor-induced G1 to S transition of the B cell cycle. J. Immunol. 133, 1283-1287.
17. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I., 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (London) 346, 561-564.
18. Mechoulam, R., Ben-Shabat, S., Hanus, L., et al., 1995. Identification of an endogenous 2-monoglyceride present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
19. Munro, S., Thomas, K.L., Abu-Shaar, M., 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature (London) 365, 61-65.
20. Pepe, S., Ruggiero, A., Tortora, G., et al., 1994. Flow cytometric detection of the RI alpha subunit of type-I cAMP-dependent protein kinase in human cells. Cytometry 15, 73-79.
21. Russell, D.H., 1978. Type I cyclic AMP-dependent protein kinase as a positive effector of growth. Adv. Cyclic Nucleotide Res. 9, 493-506.
22. 9-Tetrahydro-canabinol selectively inhibits T cell dependent humoral immune responses through direct inhibition of accessory T cell function. Immunopharmacology 26, 129-137.
23. Schatz, A.R., Lee, M., Condie, R., Pulaski, J., Kaminski, N.E., 1997. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278-287.
24. Smith, J.W., Steiner, A.L., Newberry, W.M., Parker, C.W., 1971. Cyclic adenosine 3′,5′-monophosphate in human lymphocytes. Alteration after phytohemagglutinin. J. Clin. Invest. 50, 432-441.
25. Tsuruta, L., Lee, H., Masuda, E., et al., 1995. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154, 5255-5264.
26. Watson, P., Krupinski, J., Kempinski, A., Frankenfield, C., 1994. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J. Biol. Chem. 269, 28893-28898.